Tuesday , February 7 2023

Hull's Tech Corner: The Solution for Data Extension – Hi Tech News



[ad_1]

Who has not said the following line at least once: Is it difficult to believe that we have developed rapidly in terms of the technology used everyday? I do not even talk about finding a personal computer, while imagining, the visitors behind it were told that there is no market for such a thing. I'm just talking about the recent mobile revolution.

It looks like yesterday when Steve Jobs stood on stage and much changed. The result of all these devices that we keep in our pocket and which has more computing power than a supercomputer is data just a decade ago. Lots of data

Technically, not only mobile devices, but throwing around listening to artificial intelligence, machine learning, computer vision, and other phrases you hear – these things make more data per second than ever known in the world.

Challenge with this huge abundance of data? Analyze, translate, and take an efficient intuition on which we can work. This is true for all businesses but is expanding in the world of genomics. An individual human genome includes three billion base pairs, which provides all the information and code that we see, feel, see and act.

The first complete human genome was successfully sequenced and assembled at $ 3 billion in 2003. Since then, the development of next generation sequencing (NGS) technologies has enabled faster, more scalable assemblies, and has been brought down in less than 20 years.

These technological developments quickly pave the way for true personal medicines but produce monumental amount of data at very high speeds. For this information to be useful, it is based on the medical time and its ability to interpret. Therefore, when the cost of sequencing drops dramatically, interpretation costs constantly increase, as more and more data, information and inventions are available.

The ability to analyze large amounts of data surrounding genetic screening is likely to detect rare genetic mutations and predict their potential for status. You can imagine that being able to sort this data is a time-sensitive, decisive factor. Clinicians sometimes face the life-threatening challenge, but sleep transformation is definitely detected in genetic-data heistack (billions of base-pair records).

The Israeli company, Jenox, addresses this challenge and aims to make genetic index something that is not only more accessible, but also more informative, understandable and functional.

Founded by CEO Amir Trabelsi and CTO Moss Ehhorn in GENOOX 2014 in 2014. The company is expert in translating critical genetic data into clear, timely and functional clinical responses. Their product is a cloud-based software platform that manages the entire genetic interpretation process with a raw data input in a holistic fashion that receives from the next generation sequencers to deliver evidence-based, clinical insights.

The team consists of genetic information, bioinformatics, engineers, and technical experts, whose purpose is to analyze, distribute and store genetic data.

Zenox has raised $ 12 million from Lever Healthcare Investor, Inimity Capital and GloLot Capital Partners, the leading healthcare and all-powerful Venture Capital Firms Trifunchers investing in data-based tech entrepreneurs.

In relation to how this company's technology affects our life, a child with a rare, unhealthy illness can now quickly streamline their DNA to determine the possible genetic cause. However, what does the clinician do with that information? The new clinical research publications and the rapid pace of reference literature have made Clinicians very challenging to keep pace and to respond to clinical positions, which is a perfect match with a specific genetic change.

Genoco draws back levels to understand the genomes of one person. It helps to sort the clinic through critical genetic data, clinical publications, phenotypes and family history to provide a diagnosis and personalized treatment plan based on a person's unique DNA. Very noticeable

As long as the business is concerned, Xenox has developed its customer base and has made an initial partnership with medical centers and research facilities, including the University of Michigan, the Sinai Healthcare Services, the Scrips Research Institute, the Children's National Medical Center, including the Genetic Medicine Research Center. Is there. With Washington University as well as with global pharmaceutical companies. The company has also partnered with Bioinformatics, which creates an integrated solution that reads its optical mapping that helps in detecting disease-generating variants. In addition, Xenox has been selected for analyzing the genetic data of 100,000 indexed citizens by Mosaic, the Israeli government's landmark Gnome Initiative.

Xenox does not focus solely on providing solutions for the interpretation process passed by medical researchers, but they have also helped to help in finding new inventions, advice and their knowledge. He has recently started the solution of his community, in which professionals of research and medical facilities are able to share critical research using the set of customizable tools for the first time, and can participate in a discussion discussion dedicated to disease areas in order to advance science.

The bottom line is that Jenox clinically eliminates the final barrier for an extended, timely interpretation of NGS data, which enables personalized medicine for mainstream patient care. Their platforms are used to diagnose and treat genetic disorders and cancer, as well as new drug discovery and family planning.

The technology is known to democratize and disrupt old industries which are not developed. We have seen it transport, hospitality, communication and more, but I do not think any technology expects to quickly and basically disrupt geonomy. Jenox does exactly that.

Join only for $ 5 in Jerusalem Post Premium Plus and upgrade your experience with ad-free websites and exclusive content. Click here >>


[ad_2]
Source link